title: A thromboxane A2 synthetase inhibitor, OKY-046, reduces liver damage in hepatectomy.
authors.forename: M
authors.initials: M
authors.lastname: Shimada
authors.forename: T
authors.initials: T
authors.lastname: Matsumata
authors.forename: K
authors.initials: K
authors.lastname: Shirabe
authors.forename: K
authors.initials: K
authors.lastname: Sugimachi
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000601:surgery; D006498:Hepatectomy / Q000009:adverse effects*; D006801:Humans; D008107:Liver Diseases / Q000517:prevention & control*; D008113:Liver Neoplasms / Q000601:surgery; D008689:Methacrylates / Q000627:therapeutic use*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
chemical_list: D008689:Methacrylates; D013930:Thromboxane-A Synthase; C034364:ozagrel